首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1521385

全球心律不整监测设备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Arrhythmia Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 172 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球心律不整监测设备市场需求预计将从 2023 年的 83.1 亿美元达到 2032 年近 158.7 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.46%。

心律不整监测设备是用于检测和监测患者异常心律（称为心律不整）的医疗设备。这些设备旨在透过连接到患者皮肤或植入体内的电极连续或间歇地监测心臟的电活动。这些设备透过向医疗保健提供者提供即时资料以便及时干预和治疗，在诊断和管理各种心律不整（包括心房颤动、室性心动过速和心动过缓）方面发挥着不可或缺的作用。

市场动态

由于心血管疾病盛行率上升，加上全球人口老化，心律不整发生率不断上升，心律不整监测设备市场正经历快速成长。随着高血压、糖尿病和肥胖等危险因子发生率的增加，对能够准确检测和监测异常心律的可靠心律不整监测设备的需求也增加。穿戴式监视器、植入式心臟监视器 (ICM) 和行动心臟遥测系统 (MCT) 等技术进步和创新增强了心臟资料连续监测和远端传输的能力。这些技术进步提高了患者的舒适度，能够及早发现心律不整，并促进医疗保健提供者主动管理心臟病。

此外，向个人化医疗和以病人为中心的护理模式的转变推动了心律不整监测设备的采用。这些设备使患者能够透过提供即时心律资料和有关潜在心臟异常的警报来管理他们的医疗保健。增强患者的参与度和对治疗方案的依从性有助于改善临床结果并降低与未诊断或未经治疗的心律不整併发症相关的医疗费用。然而，报销限制和成本限制可能会影响市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球心律不整监测设备市场的各个细分市场进行了包容性评估。心律不整监测设备产业的成长和趋势为这项研究提供了整体方法。

市场区隔

心律不整监测设备市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按类型

心电图
植入式监视器
动态心电图监测仪
移动心臟遥测

按申请

心搏过缓
心跳过速
心房震颤
心室颤动
宫缩过早
其他的

按最终用途

医院和诊所
诊断中心
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲心律不整监测设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。心律不整监测设备市场的主要参与者包括AliveCor Inc.、Applied Cardiac Systems、BioTelemetry Inc.、Biotronik、FU.K.Uda Denshi Co. Ltd.、GE Healthcare、IRhythm、Medi-Lynx、St. Jude Medical (Abbott ) ）、美敦力（Medtronic）、日本光电公司（Nihon Kohden Corporation）、Nuubo、Spacelabs Healthcare。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：心律不整监测设备公司的竞争格局

心律不整监测设备市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
AliveCor Inc.

公司简介
公司收入
产品
最近的发展

Applied Cardiac Systems

公司简介
公司收入
产品
最近的发展

BioTelemetry Inc.

公司简介
公司收入
产品
最近的发展

Biotronik

公司简介
公司收入
产品
最近的发展

FU.K.Uda Denshi Co. Ltd.

公司简介
公司收入
产品
最近的发展

GE Healthcare

公司简介
公司收入
产品
最近的发展

IRhythm

公司简介
公司收入
产品
最近的发展

Medi-Lynx

公司简介
公司收入
产品
最近的发展

St. Jude Medical (Abbott)

公司简介
公司收入
产品
最近的发展

Medtronic

公司简介
公司收入
产品
最近的发展

Nihon Kohden Corporation

公司简介
公司收入
产品
最近的发展

Nuubo

公司简介
公司收入
产品
最近的发展

Spacelabs Healthcare

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112115264

The global demand for Arrhythmia Monitoring Devices Market is presumed to reach the market size of nearly USD 15.87 Billion by 2032 from USD 8.31 Billion in 2023 with a CAGR of 7.46% under the study period 2024-2032.

Arrhythmia monitoring devices are medical devices utilized to detect and monitor abnormal heart rhythms, known as arrhythmias, in patients. These devices are designed to continuously or intermittently monitor the heart's electrical activity through electrodes attached to the patient's skin or implanted within the body. These devices play an integral role in diagnosing and managing various arrhythmias, including atrial fibrillation, ventricular tachycardia, and bradycardia, by providing real-time data to healthcare providers for timely intervention and treatment.

MARKET DYNAMICS

The arrhythmia monitoring devices market is experiencing rapid growth fueled by the rising prevalence of cardiovascular diseases, together with the growing aging population globally, which is contributing to the rising incidence of arrhythmias. As the incidence of risk factors such as hypertension, diabetes, and obesity increases, so does the demand for reliable arrhythmia monitoring devices that can accurately detect and monitor abnormal heart rhythms. Technological advancements and innovations such as wearable monitors, implantable cardiac monitors (ICMs), and mobile cardiac telemetry systems (MCTs) offer enhanced capabilities for continuous monitoring and remote transmission of cardiac data. These technological advancements improve patient comfort, enable early detection of arrhythmias, and facilitate healthcare providers' proactive management of cardiac conditions.

Moreover, the shift towards personalized medicine and patient-centric care models drives the adoption of arrhythmia monitoring devices. These devices enable patients to manage their healthcare by providing real-time heart rhythm data and alerts about potential cardiac abnormalities. Enhanced patient engagement and adherence to treatment regimens contribute to enhanced clinical outcomes and reduced healthcare costs associated with complications from undiagnosed or untreated arrhythmias. However, reimbursement limitations and cost constraints may impact market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Arrhythmia Monitoring Devices. The growth and trends of Arrhythmia Monitoring Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Arrhythmia Monitoring Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

ECG
Implantable Monitors
Holter Monitors
Mobile Cardiac Telemetry

By Application

Bradycardia
Tachycardia
Atrial Fibrillation
Ventricular Fibrillation
Premature Contraction
Others

By End-use

Hospitals & Clinics
Diagnostic Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Arrhythmia Monitoring Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Arrhythmia Monitoring Devices market include AliveCor Inc., Applied Cardiac Systems, BioTelemetry Inc., Biotronik, FU.K.Uda Denshi Co. Ltd., GE Healthcare, IRhythm, Medi-Lynx, St. Jude Medical (Abbott), Medtronic, Nihon Kohden Corporation, Nuubo, Spacelabs Healthcare. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ARRHYTHMIA MONITORING DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. ECG Historic and Forecast Sales By Regions
5.4. Implantable Monitors Historic and Forecast Sales By Regions
5.5. Holter Monitors Historic and Forecast Sales By Regions
5.6. Mobile Cardiac Telemetry Historic and Forecast Sales By Regions

6. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Bradycardia Historic and Forecast Sales By Regions
6.4. Tachycardia Historic and Forecast Sales By Regions
6.5. Atrial Fibrillation Historic and Forecast Sales By Regions
6.6. Ventricular Fibrillation Historic and Forecast Sales By Regions
6.7. Premature Contraction Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
7.4. Diagnostic Centers Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ARRHYTHMIA MONITORING DEVICES COMPANIES

9.1. Arrhythmia Monitoring Devices Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ARRHYTHMIA MONITORING DEVICES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. AliveCor Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Applied Cardiac Systems
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. BioTelemetry Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Biotronik
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. FU.K.Uda Denshi Co. Ltd.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. GE Healthcare
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. IRhythm
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Medi-Lynx
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. St. Jude Medical (Abbott)
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Medtronic
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Nihon Kohden Corporation
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Nuubo
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Spacelabs Healthcare
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments